4//SEC Filing
Waltermire Robert E. 4
Accession 0001628280-25-010224
CIK 0001157601other
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 9:24 PM ET
Size
6.9 KB
Accession
0001628280-25-010224
Insider Transaction Report
Form 4
Waltermire Robert E.
Senior VP, Chief Pharma Dev.
Transactions
- Sale
Common Stock
2025-02-28$340.99/sh−1,052$358,717→ 3,903 total - Sale
Common Stock
2025-02-28$341.55/sh−175$59,771→ 3,728 total
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $340.495 to $341.415, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and the footnote below.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $341.52 to $341.57, inclusive.
Documents
Issuer
MADRIGAL PHARMACEUTICALS, INC.
CIK 0001157601
Entity typeother
Related Parties
1- filerCIK 0001876996
Filing Metadata
- Form type
- 4
- Filed
- Mar 3, 7:00 PM ET
- Accepted
- Mar 4, 9:24 PM ET
- Size
- 6.9 KB